BSE filing, BSE: 543500. Summary written from the filing by ALFA Finder's alert engine.
Evoq Remedies Ltd: key numbers
- Share price
- ₹1.61
- Market cap
- ₹4.01 Cr
- Revenue (annual)
- ₹25.51 Cr
- Net profit (annual)
- ₹-0.24 Cr
- P/E (TTM)
- -16.7×Sector 52.0×
- Promoter holding
- 0.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Evoq Remedies Ltd
All →Evoq Remedies Insolvency Petition
NCLT admitted CIRP against Evoq Remedies Ltd for a Rs.1.95 Crore operational debt. An IRP has been appointed, and a moratorium is in effect.
- Value
- ₹1.95 Cr
Evoq Remedies Insolvency Petition
An operational creditor has filed an insolvency petition against Evoq Remedies under IBC Section 9. The NCLT admission initiates the CIRP process, posing significant risk for shareholders.
Evoq Remedies Financial Results
Evoq Remedies Limited reported audited financial results for the year ended March 31, 2026. The auditor issued a qualified opinion citing material uncertainty regarding going concern.
Evoq Remedies H2 FY26 Results: Net Loss of ₹0.3 Cr
Evoq Remedies Ltd reported a net loss of ₹0.3 Cr for H2 FY26.
- Key figure
- Net loss ₹0.3 Cr
Evoq Remedies Financial Results
Evoq Remedies Limited reported annual revenue of ₹26.76 Crore for FY2026. The board also appointed M/s. Jay Pandya & Associates as secretarial auditors for FY2025-26.
- Value
- ₹26.76 Cr
Evoq Remedies Board Meeting Date
Evoq Remedies rescheduled its board meeting from May 27 to May 30, 2026. Directors will consider audited financial results for the fiscal year ended March 31.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.